Trial register facet
Trial records in growth hormone deficiency and growth-hormone secretagogue pharmacology — page 3
57 records bearing on growth hormone deficiency and growth-hormone secretagogue pharmacology.
Showing 0 records on this page
Records
57 documents · page 3 of 3
Table 1. Trial records on this page. The table sorts on any column and filters on the controls above; both operate on the records shown on this page only.
| Record | Compound | Phase | Status | Design | Randomised | Year | Certainty |
|---|---|---|---|---|---|---|---|
| GNRH-DIAGNOSTIC-REGIONAL-JPprogramme record | Gonadorelin | Phase 3 | Reported | Randomised, double-blind, placebo-controlled | — | — | Very low |
| GNRH-PULSATILE-HH-PKprogramme record | Gonadorelin | Phase 1 | Reported | Phase 1 ascending dose | — | — | Very low |
| SERM-DIAGNOSTIC-DDIprogramme record | Sermorelin | Phase 1 | Reported | Randomised crossover | — | — | Very low |
| GNRH-DIAGNOSTIC-BODY-COMPprogramme record | Gonadorelin | — | Reported | Randomised, double-blind, placebo-controlled | — | — | Very low |
| GNRH-PULSATILE-HH-RENAL-IMPprogramme record | Gonadorelin | Phase 1 | Reported | Phase 1 ascending dose | — | — | Very low |
| GNRH-DIAGNOSTIC-QOLprogramme record | Gonadorelin | — | Reported | Randomised, double-blind, placebo-controlled | — | — | Very low |
| GNRH-PULSATILE-HH-HEPATIC-IMPprogramme record | Gonadorelin | Phase 1 | Reported | Phase 1 ascending dose | — | — | Very low |
| SERM-DIAGNOSTIC-RENAL-IMPprogramme record | Sermorelin | Phase 1 | Reported | Phase 1 ascending dose | — | — | Very low |
| GNRH-PULSATILE-HH-DDIprogramme record | Gonadorelin | Phase 1 | Reported | Randomised crossover | — | — | Very low |
page 3 of 3